State Food and Drug Administration vigorously rectifies the market of traditional Chinese Medicine

Yesterday (June 20), the State Food and Drug Administration issued four follow-up inspection circulars, two of which are related to the enterprises of Chinese herbal pieces, both of which have been withdrawn the relevant GMP certificates, and their illegal behaviors have been investigated according to law ▍ according to the notice of the State Food and drug administration, one of the pharmaceutical enterprises was received GMP due to incomplete inspection report items, lack of sulfur dioxide, extract and other items; as well as the purchased medicinal materials did not undergo self inspection and entrusted inspection, and the finished product inspection report quoted the inspection results of the supplier Another enterprise received GMP because the laboratory failed to carry out pesticide residue test on the involved varieties according to the quality standards; there were many problems in the laboratory's management of reagents, control substances and retention samples; the material management of the original medicine warehouse was not in place, etc It can be seen that the inspection of Chinese herbal pieces is becoming more and more intensive and strict Since the establishment of the State Food and Drug Administration in March this year, after Jiao Hong took office as the director, he focused on the supervision of traditional Chinese medicine On April 26, Jiao Hong, director of the State Food and drug administration, presided over the "Symposium on the supervision of Chinese Herbal Pieces" to check the quality management of Chinese herbal pieces At the meeting, experts believed that there were problems in the current quality management of Chinese herbal pieces, such as inadequate implementation of the main responsibility of the enterprise, nonstandard cultivation of upstream Chinese herbal medicines, non traceability of the circulation of medicinal materials, and imperfect quality standards They also suggested that we should start from the source of Chinese herbal medicines, urge the enterprise to fulfill the main responsibility, standardize the primary processing of the origin, establish the circulation traceability system of Chinese herbal medicines, and strengthen the quality control of Chinese herbal medicines 。
Subsequently, on May 9, CCTV's "live news room" focused on reporting on Bozhou, the largest distribution center of traditional Chinese medicine in China, exposing the problem of "adulterated" traditional Chinese medicine This makes the quality of traditional Chinese medicine become the focus of public opinion again In fact, in the strict monitoring of the work of Chinese herbal pieces, not only the State Food and drug administration, but also the local drug administration departments have been increasing their efforts and intensity Anhui, as a big province of traditional Chinese medicine, has also made great moves in the supervision of traditional Chinese medicine Recently, Anhui Provincial Agricultural Committee issued the notice on strengthening the supervision of the quality and safety of the production of traditional Chinese medicine, which made it clear that we should strengthen the control of risk sources, strictly control the inputs in each link of the field cultivation and production management of traditional Chinese medicine, and ensure that the detection indicators of agricultural residues and heavy metals of traditional Chinese medicine meet the national standards At the same time, there are also clear requirements for reducing the application of chemical fertilizer, minimizing the application of pesticides, and establishing and improving the quality and safety traceability system of traditional Chinese medicine ▍ the market is bleak, aristocratic medicine is no longer aristocratic? In recent years, the soaring price of traditional Chinese medicine has attracted great attention of the society According to the data, the prices of some varieties of traditional Chinese medicine have doubled several times by the end of 2017 alone Many people think that traditional Chinese medicine will become noble medicine Now, however, it seems that this is not the case Relevant people said that due to the increased efforts made by the drug regulatory authorities to investigate and deal with the quality of medicinal materials from pharmaceutical factories, distributors, and large and small traditional Chinese medicine hospitals, medicines with sulfur, heavy metals, agricultural residues exceeding the standard and effective content not up to the standard of the Chinese Pharmacopoeia will have nowhere to sell It is understood that at present, the trading volume of traditional Chinese medicine market has declined, and the sales of medicinal materials in many places are in trouble In the past few years, the prices of most of the medicinal materials have gone up crazily Because of the blind expansion of cultivation by pharmaceutical farmers, it is bound to lead to overproduction and further impact on the prices According to an example, in the first half of 2015, when the new orange peel (produced in Jiangxi) was not accepted, the price once rose to about 60 yuan, and the selling price of pieces was 65 yuan At present, the selling price of pieces in the market has dropped to about 34 yuan According to the insiders, under the stimulation of the price rise for many years in a row, there are also surplus medicinal materials produced: dangshen, angelica and Astragalus Scutellaria baicalensis Georgi, Atractylodes macrocephala, Angelica dahurica, dioscorea japonicus, Radix gleanei, Lilium, Platycodon grandiflorum, Pinellia ternata, Yuanhu, Danshen, Danpi, Fangfeng, Ligusticum chuanxiong, Alisma orientalis, plantain, Gardenia jasminoides, burdock, Kochia, honeysuckle, chrysanthemum, rose, Schizonepeta tenuifolia, Schizonepeta tenuifolia, Anemarrhena, Radix Gastrodiae, Ophiopogon japonicus, catnipponia, kudidin, Shegan, shawanzi, Baiqian, etc At the same time, under the stimulation of high prices, some wild medicinal materials are also in oversupply and prices fall back rationally Such as: scorpion, centipede, jiuxiangchong, Huangjing, Shichangpu, Bletilla, Polyporus, etc Moreover, every time the price of medicinal materials soars, it is more or less related to the stock In the past few years, when the drug market has been booming, the main driving force of the price rise is the hoarding of buying goods Under the temptation of high profits, not only drug companies rush to buy goods and hoard them, but also many other industries join in the army of suppressing goods Some people in the industry said to the author that the industry is becoming more and more standardized, and the state's flight inspection is strict, many enterprises dare not hoard too much inventory Compared with the past, this year is generally in a downturn It should be said that these two years belong to a period of chaos Under the influence of many factors, such as overproduction, large inventory, weak demand and market consolidation, the current drug market is in a downturn Chinese medicine, really no longer noble?